Free Trial

Evoke (LON:EVOK) Stock Price Down 17.6% - Time to Sell?

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report)'s share price traded down 17.6% during trading on Wednesday . The stock traded as low as GBX 57.50 ($0.74) and last traded at GBX 58.85 ($0.76). 5,671,470 shares were traded during mid-day trading, an increase of 181% from the average session volume of 2,015,258 shares. The stock had previously closed at GBX 71.40 ($0.92).

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Berenberg Bank dropped their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a report on Wednesday, December 4th. Jefferies Financial Group reissued a "buy" rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research note on Monday, December 16th.

Get Our Latest Stock Analysis on EVOK

Evoke Price Performance

The stock's fifty day moving average price is GBX 68.88 and its 200 day moving average price is GBX 63.49. The stock has a market capitalization of £224.78 million, a P/E ratio of -1.26 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, sell-side analysts expect that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Buying and Selling at Evoke

In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the company's stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Insiders own 27.00% of the company's stock.

About Evoke

(Get Free Report)

Recommended Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads